Anticoagulation

Intensive LDL-C Lowering with Evolocumab Does Not Reduce Early Vein Graft Failure After CABG

Radcliffe Vascular

HI-PRO: Low-Dose Apixaban Reduces Recurrent VTE in Provoked Cases with Enduring Risk

Radcliffe Vascular

ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Jeffrey Weitz, Davide Capodanno

Watch time: 18m 3s (6 videos)
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s

Nazli Okumus, Ashley Park, Eugene Yuridistky, et al

Read time: 29m 12s
Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Lale Tokgözoğlu, et al

Watch time: 35m 13s (4 videos)
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey

Watch time: 11m 15s
View from the Thoraxcenter: TCT 23 Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Listen time: 30m 37s
ESC 23: The ONCO DVT Study

Yugo Yamashita

Watch time: 4m 8s

Nazli Okumus, Ashley Park, Eugene Yuridistky, et al

Read time: 29m 12s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Jeffrey Weitz, Davide Capodanno

Watch time: 18m 3s (6 videos)
Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Lale Tokgözoğlu, et al

Watch time: 35m 13s (4 videos)
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s
ESC 23: The ONCO DVT Study

Yugo Yamashita

Watch time: 4m 8s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey

Watch time: 11m 15s
View from the Thoraxcenter: TCT 23 Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Listen time: 30m 37s
HI-PRO: Low-Dose Apixaban Reduces Recurrent VTE in Provoked Cases with Enduring Risk

Radcliffe Vascular

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s
Intensive LDL-C Lowering with Evolocumab Does Not Reduce Early Vein Graft Failure After CABG

Radcliffe Vascular

ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s

Media

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Jeffrey Weitz, Davide Capodanno

Watch time: 18m 3s (6 videos)
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s
Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Lale Tokgözoğlu, et al

Watch time: 35m 13s (4 videos)
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
ESC 23: The ONCO DVT Study

Yugo Yamashita

Watch time: 4m 8s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey

Watch time: 11m 15s
Radcliffe & CardioNerds @AHA22: The PREVENT-HD Randomized Clinical Trial

Kahtan Fadah, Gregory Piazza

Watch time: 15m 37s

Articles

Management of Venous Thromboembolism

Nazli Okumus

,

Ashley Park

,

Eugene Yuridistky

,

James M Horowitz

,

Michael A Solomon

,

Published:

27 November 2024

Citation:

US Cardiology Review 2024;18:e21.

DOI:

https://doi.org/10.15420/usc.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2512
  • Downloads: Downloads 326
  • Citations: 1
  • Read time: 29m 12s